Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,071 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nafion: A Flexible Template for Selective Structuring.
Bunkin NF, Bolotskova PN, Gudkov SV, Khuong MT, Kozlov VA, Timchenko SL, Voronov VV, Novakovskaya YV. Bunkin NF, et al. Among authors: kozlov va. Polymers (Basel). 2024 Mar 8;16(6):744. doi: 10.3390/polym16060744. Polymers (Basel). 2024. PMID: 38543350 Free PMC article.
Evaluation of the Immunosafety of Cucurbit[n]uril In Vivo.
Pashkina E, Aktanova A, Boeva O, Bykova M, Gavrilova E, Goiman E, Kovalenko E, Saleh N, Grishina L, Kozlov V. Pashkina E, et al. Among authors: kozlov v. Pharmaceutics. 2024 Jan 19;16(1):127. doi: 10.3390/pharmaceutics16010127. Pharmaceutics. 2024. PMID: 38276497 Free PMC article.
In Vitro Antiviral Activity of a New Indol-3-carboxylic Acid Derivative Against SARS-CoV-2.
Narovlyansky AN, Filimonova MV, Tsyshkova NG, Pronin AV, Grebennikova TV, Karamov EV, Larichev VF, Kornilayeva GV, Fedyakina IT, Dolzhikova IV, Mezentseva MV, Isaeva EI, Poloskov VV, Koval LS, Marinchenko VP, Surinova VI, Filimonov AS, Shitova AA, Soldatova OV, Sanin AV, Zubashev IK, Ponomarev AV, Veselovsky VV, Kozlov VV, Stepanov AV, Khomich AV, Kozlov VS, Ivanov SA, Shegai PV, Kaprin AD, Ershov FI, Gintsburg AL. Narovlyansky AN, et al. Among authors: kozlov vv, kozlov vs. Acta Naturae. 2023 Oct-Dec;15(4):83-91. doi: 10.32607/actanaturae.26623. Acta Naturae. 2023. PMID: 38234608 Free PMC article.
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.
Motzer RJ, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Alekseev B, Rha SY, Merchan J, Goh JC, Lalani AA, De Giorgi U, Melichar B, Hong SH, Gurney H, Méndez-Vidal MJ, Kopyltsov E, Tjulandin S, Gordoa TA, Kozlov V, Alyasova A, Winquist E, Maroto P, Kim M, Peer A, Procopio G, Takagi T, Wong S, Bedke J, Schmidinger M, Rodriguez-Lopez K, Burgents J, He C, Okpara CE, McKenzie J, Choueiri TK; CLEAR Trial Investigators. Motzer RJ, et al. Among authors: kozlov v. J Clin Oncol. 2024 Apr 10;42(11):1222-1228. doi: 10.1200/JCO.23.01569. Epub 2024 Jan 16. J Clin Oncol. 2024. PMID: 38227898 Free article. Clinical Trial.
Comparison of EEP and TURP long-term outcomes: systematic review and meta-analysis.
Morozov A, Taratkin M, Shpikina A, Ehrlich Y, McFarland J, Dymov A, Kozlov V, Fajkovic H, Rivas JG, Lusuardi L, Teoh JY, Herrmann T, Baniel J, Enikeev D. Morozov A, et al. Among authors: kozlov v. World J Urol. 2023 Dec;41(12):3471-3483. doi: 10.1007/s00345-023-04666-8. Epub 2023 Nov 18. World J Urol. 2023. PMID: 37980297 Review.
1,071 results